Page last updated: 2024-12-05

berlition

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

berlition: antioxidant preparation containing alpha-lipoic acid, used in the neuroprotective therapy of chronic brain ischemia for correction of free-radical processes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

(R)-lipoic acid : The (R)-enantiomer of lipoic acid. A vitamin-like, C8 thia fatty acid with anti-oxidant properties. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

lipoic acid : A heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6112
CHEMBL ID134342
CHEBI ID30314
SCHEMBL ID7924
MeSH IDM0526606

Synonyms (112)

Synonym
r-la
(+)-alpha-lipoic acid
thioctic acid d-form
(r)-1,2-dithiolane-3-pentanoic acid
1200-22-2
(r)-1,2-dithiolane-3-valeric acid
(r)-6,8-thioctic acid
(r)-(+)-lipoic acid
5-[(3r)-1,2-dithiolan-3-yl]pentanoic acid
r-(+)-lipoic acid
(r)-lipoic acid
(r)-(+)-lipoate
CHEBI:30314 ,
LOPAC0_001129
EU-0101129
LMFA01130001
r-lipoic acid
1,2-dithiolane-3r-pentanoic acid
heparlipon
thioctanoic acid
5-[(3r)-dithiolan-3-yl]pentanoic acid
lipoic acid
d-thioctic acid
(r)-(+)-1,2-dithiolane-3-pentanoic acid, 97%
NCGC00094396-03
r-(+)-thioctic acid
r-alpha-lipoic acid
DB00166
NCGC00094396-01
(?)-alpha-lipoic acid
NCGC00094396-02
berlition
thiogamma
T 5625
( inverted question mark)-alpha-lipoic acid
AC-11124
( inverted question mark)-1,2-dithiolane-3-pentanoic acid
L0207
(r)-alpha-lipoic acid
(r)-thioctic acid
NCGC00094396-04
tioctic acid
CHEMBL134342 ,
bdbm50106731
(r)-(+)-1,2-dithiolane-3-pentanoic acid
(3r)-1,2-dithiolane-3-pentanoic acid
A804416
5-[(3r)-3-dithiolanyl]pentanoic acid
NCGC00094396-05
HMS3263B19
r-(+)-alpha-lipoic acid
(r)-6,8-dithiooctanoic acid
(r)-5-(1,2-dithiolan-3-yl)pentanoic acid
(r)-(+)-a-lipoic acid
CCG-205204
thioctic acid, d form
thioderm
(r)-(+)-alpha-lipoic acid
byodinoral 300
unii-vll71ebs9z
tiobec retard
1,2-dithiolane-3-pentanoic acid, (r)-
vll71ebs9z ,
r-lipoate
lipoec
alpha-(+)-lipoic acid
tiobec
S3998
(+/-)-alpha-lipoic acid
LP01129
d-thioctic acid [who-dd]
thioctic acid d-form [mi]
arlipoic acid [inn]
arlipoic acid
.alpha.-lipoic acid, d-
1,2-dithiolane-3-pentanoic acid, (3r)-
r-alpha lipoic acid
AKOS015892879
gtpl4822
AGBQKNBQESQNJD-SSDOTTSWSA-N
SCHEMBL7924
CS-5076
tox21_501129
NCGC00261814-01
(y)-alpha-lipoic acid
Q-201824
HY-18733
mfcd01631142
DTXSID20152651
(+)-a-lipoic acid
J-004243
AC-8133
(r)-(+)-alpha-lipoic acid, analytical standard
(r)-(+)-alpha-lipoic acid, >=98.0% (hplc)
sr-01000076163
SR-01000076163-1
(r)-5-(1,2-dithiolan-3-yl)pentanoicacid
(+)-thioctic acid
Q27887203
AS-11009
SDCCGSBI-0051097.P002
NCGC00094396-06
r)-(+)--lipoic acid
(+)- alpha -lipoic acid
(+)-|a-lipoic acid
(r)-(+)-?-lipoic acid
(r)-(+)--lipoic acid;r-(+)-thioctic acid
EN300-7352963
lipoic acid (standard)
HY-18733R
CS-0694941
Z1269228108

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The findings demonstrated herein therefore strongly suggest that the amphiphilic character enhances the bioavailability of the antioxidants and allows for a selective targeting of mitochondria."( Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
Böker, J; Durand, G; Hardeland, R; Ortial, S; Pappolla, MA; Poeggeler, B; Polidori, A; Pucci, B, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (7 Product(s))

Product Categories

Product CategoryProducts
Active Lifestyle & Fitness1
Vitamins & Supplements5
Professional Supplements1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
ALLMAX Nutrition R+ ALA™ -- 150 mg - 60 CapsulesALLMAX NutritionActive Lifestyle & FitnessR-Alpha-Lipoic Acid2024-11-29 10:47:42
Aurora NutraScience Active-Liposomal Creatine + GAA & R-ALA Drink Mix -- 30 PacketsAurora NutraScienceVitamins & SupplementsR-Alpha-Lipoic Acid, Guanidinoacetic Acid2024-11-29 10:47:42
Aurora NutraScience Mega-Liposomal R-ALA Organic Fruit -- 16 fl ozAurora NutraScienceVitamins & SupplementsR-Alpha-Lipoic Acid, Coenzyme Q10, L-Carnitine2024-11-29 10:47:42
DaVinci Laboratories Prostate Health -- 60 CapsulesDaVinci LaboratoriesProfessional SupplementsVitamin C, R-Alpha-Lipoic Acid, Vitamin E, Folate, Vitamin E, Lycopene, Vitamin B6, Resveratrol, Vitamin B62024-11-29 10:47:42
Emerald Labs PureWay-C® -- 500 mg - 90 Vegetable CapsEmerald LabsVitamins & SupplementsR-Alpha Lipoic Acid2024-11-29 10:47:42
Jarrow Formulas R-Alpha Lipoic Acid with Biotin -- 60 Veggie CapsJarrow FormulasVitamins & SupplementsR-Alpha-Lipoic Acid, Biotin, Microcrystallinecellulose, calcium phosphate2024-11-29 10:47:42
LivOn Laboratories Lypo Spheric™ R-ALA -- 30 PacketsLivOn LaboratoriesVitamins & SupplementsR-Alpha-Lipoic Acid2024-11-29 10:47:42

Roles (3)

RoleDescription
prosthetic groupA tightly bound, specific nonpolypeptide unit in a protein determining and involved in its biological activity.
nutraceuticalA product in capsule, tablet or liquid form that provide essential nutrients, such as a vitamin, an essential mineral, a protein, an herb, or similar nutritional substance.
cofactorAn organic molecule or ion (usually a metal ion) that is required by an enzyme for its activity. It may be attached either loosely (coenzyme) or tightly (prosthetic group).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
lipoic acidA heterocyclic thia fatty acid comprising pentanoic acid with a 1,2-dithiolan-3-yl group at the 5-position.
dithiolanes
heterocyclic fatty acidAny fatty acid containing a ring composed of atoms including at least one heteroatom.
thia fatty acidAny fatty acid having at least one of the chain methylene groups replaced by sulfur. Members of this group are believed to have important pharmacological (antioxidant and antiatherosclerosis) properties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (13)

PathwayProteinsCompounds
Glycine and Serine Metabolism2452
Ammonia Recycling1227
Dimethylglycine Dehydrogenase Deficiency2452
Dihydropyrimidine Dehydrogenase Deficiency (DHPD)2452
Sarcosinemia2452
Non-Ketotic Hyperglycinemia2452
Hyperglycinemia, Non-Ketotic2452
3-Phosphoglycerate Dehydrogenase Deficiency2452
Lipoic Acid Metabolism310
Arsenate Detoxification716
Metabolic Epileptic Disorders2589
Folic acid network070
Selenium micronutrient network095

Protein Targets (17)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency0.89130.003245.467312,589.2998AID2517
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency63.09570.004023.8416100.0000AID485290
endonuclease IVEscherichia coliPotency0.89130.707912.432431.6228AID1708
thioredoxin reductaseRattus norvegicus (Norway rat)Potency45.00820.100020.879379.4328AID588453
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency37.68580.035520.977089.1251AID504332
Bloom syndrome protein isoform 1Homo sapiens (human)Potency7.94330.540617.639296.1227AID2364; AID2528
peripheral myelin protein 22 isoform 1Homo sapiens (human)Potency33.807823.934123.934123.9341AID1967
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.89130.010039.53711,122.0200AID1479
DNA polymerase eta isoform 1Homo sapiens (human)Potency0.25120.100028.9256213.3130AID588591
M-phase phosphoprotein 8Homo sapiens (human)Potency50.11870.177824.735279.4328AID488949
lamin isoform A-delta10Homo sapiens (human)Potency17.91810.891312.067628.1838AID1459; AID1487
ATP-dependent phosphofructokinaseTrypanosoma brucei brucei TREU927Potency15.10140.060110.745337.9330AID485368
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Bile salt export pumpHomo sapiens (human)IC50 (µMol)1,000.00000.11007.190310.0000AID1449628
CholinesteraseHomo sapiens (human)IC50 (µMol)1,000.00000.00001.559910.0000AID241230; AID625547
AcetylcholinesteraseHomo sapiens (human)IC50 (µMol)666.66700.00000.933210.0000AID241200; AID314091; AID625546
TAR DNA-binding protein 43Homo sapiens (human)IC50 (µMol)19.952610.000010.000010.0000AID1666489
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Nuclear receptor subfamily 1 group I member 2Homo sapiens (human)EC50 (µMol)2.80000.00203.519610.0000AID1215094
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (76)

Processvia Protein(s)Taxonomy
negative regulation of DNA-templated transcriptionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
regulation of DNA-templated transcriptionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
xenobiotic metabolic processNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
signal transductionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
steroid metabolic processNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
positive regulation of gene expressionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
intracellular receptor signaling pathwayNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
xenobiotic catabolic processNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
xenobiotic transportNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
positive regulation of DNA-templated transcriptionNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
positive regulation of transcription by RNA polymerase IINuclear receptor subfamily 1 group I member 2Homo sapiens (human)
cell differentiationNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IINuclear receptor subfamily 1 group I member 2Homo sapiens (human)
fatty acid metabolic processBile salt export pumpHomo sapiens (human)
bile acid biosynthetic processBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processBile salt export pumpHomo sapiens (human)
xenobiotic transmembrane transportBile salt export pumpHomo sapiens (human)
response to oxidative stressBile salt export pumpHomo sapiens (human)
bile acid metabolic processBile salt export pumpHomo sapiens (human)
response to organic cyclic compoundBile salt export pumpHomo sapiens (human)
bile acid and bile salt transportBile salt export pumpHomo sapiens (human)
canalicular bile acid transportBile salt export pumpHomo sapiens (human)
protein ubiquitinationBile salt export pumpHomo sapiens (human)
regulation of fatty acid beta-oxidationBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transportBile salt export pumpHomo sapiens (human)
bile acid signaling pathwayBile salt export pumpHomo sapiens (human)
cholesterol homeostasisBile salt export pumpHomo sapiens (human)
response to estrogenBile salt export pumpHomo sapiens (human)
response to ethanolBile salt export pumpHomo sapiens (human)
xenobiotic export from cellBile salt export pumpHomo sapiens (human)
lipid homeostasisBile salt export pumpHomo sapiens (human)
phospholipid homeostasisBile salt export pumpHomo sapiens (human)
positive regulation of bile acid secretionBile salt export pumpHomo sapiens (human)
regulation of bile acid metabolic processBile salt export pumpHomo sapiens (human)
transmembrane transportBile salt export pumpHomo sapiens (human)
xenobiotic metabolic processCholinesteraseHomo sapiens (human)
learningCholinesteraseHomo sapiens (human)
negative regulation of cell population proliferationCholinesteraseHomo sapiens (human)
neuroblast differentiationCholinesteraseHomo sapiens (human)
peptide hormone processingCholinesteraseHomo sapiens (human)
response to alkaloidCholinesteraseHomo sapiens (human)
cocaine metabolic processCholinesteraseHomo sapiens (human)
negative regulation of synaptic transmissionCholinesteraseHomo sapiens (human)
response to glucocorticoidCholinesteraseHomo sapiens (human)
response to folic acidCholinesteraseHomo sapiens (human)
choline metabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic processCholinesteraseHomo sapiens (human)
acetylcholine catabolic process in synaptic cleftAcetylcholinesteraseHomo sapiens (human)
regulation of receptor recyclingAcetylcholinesteraseHomo sapiens (human)
osteoblast developmentAcetylcholinesteraseHomo sapiens (human)
acetylcholine catabolic processAcetylcholinesteraseHomo sapiens (human)
cell adhesionAcetylcholinesteraseHomo sapiens (human)
nervous system developmentAcetylcholinesteraseHomo sapiens (human)
synapse assemblyAcetylcholinesteraseHomo sapiens (human)
receptor internalizationAcetylcholinesteraseHomo sapiens (human)
negative regulation of synaptic transmission, cholinergicAcetylcholinesteraseHomo sapiens (human)
amyloid precursor protein metabolic processAcetylcholinesteraseHomo sapiens (human)
positive regulation of protein secretionAcetylcholinesteraseHomo sapiens (human)
retina development in camera-type eyeAcetylcholinesteraseHomo sapiens (human)
acetylcholine receptor signaling pathwayAcetylcholinesteraseHomo sapiens (human)
positive regulation of cold-induced thermogenesisAcetylcholinesteraseHomo sapiens (human)
negative regulation of protein phosphorylationTAR DNA-binding protein 43Homo sapiens (human)
mRNA processingTAR DNA-binding protein 43Homo sapiens (human)
RNA splicingTAR DNA-binding protein 43Homo sapiens (human)
negative regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
regulation of protein stabilityTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of insulin secretionTAR DNA-binding protein 43Homo sapiens (human)
response to endoplasmic reticulum stressTAR DNA-binding protein 43Homo sapiens (human)
positive regulation of protein import into nucleusTAR DNA-binding protein 43Homo sapiens (human)
regulation of circadian rhythmTAR DNA-binding protein 43Homo sapiens (human)
regulation of apoptotic processTAR DNA-binding protein 43Homo sapiens (human)
negative regulation by host of viral transcriptionTAR DNA-binding protein 43Homo sapiens (human)
rhythmic processTAR DNA-binding protein 43Homo sapiens (human)
regulation of cell cycleTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA destabilizationTAR DNA-binding protein 43Homo sapiens (human)
3'-UTR-mediated mRNA stabilizationTAR DNA-binding protein 43Homo sapiens (human)
nuclear inner membrane organizationTAR DNA-binding protein 43Homo sapiens (human)
amyloid fibril formationTAR DNA-binding protein 43Homo sapiens (human)
regulation of gene expressionTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (37)

Processvia Protein(s)Taxonomy
RNA polymerase II transcription regulatory region sequence-specific DNA bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nuclear receptor activityNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
protein bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
zinc ion bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nuclear receptor bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
sequence-specific double-stranded DNA bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
protein bindingBile salt export pumpHomo sapiens (human)
ATP bindingBile salt export pumpHomo sapiens (human)
ABC-type xenobiotic transporter activityBile salt export pumpHomo sapiens (human)
bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
canalicular bile acid transmembrane transporter activityBile salt export pumpHomo sapiens (human)
carbohydrate transmembrane transporter activityBile salt export pumpHomo sapiens (human)
ABC-type bile acid transporter activityBile salt export pumpHomo sapiens (human)
ATP hydrolysis activityBile salt export pumpHomo sapiens (human)
amyloid-beta bindingCholinesteraseHomo sapiens (human)
catalytic activityCholinesteraseHomo sapiens (human)
acetylcholinesterase activityCholinesteraseHomo sapiens (human)
cholinesterase activityCholinesteraseHomo sapiens (human)
protein bindingCholinesteraseHomo sapiens (human)
hydrolase activity, acting on ester bondsCholinesteraseHomo sapiens (human)
enzyme bindingCholinesteraseHomo sapiens (human)
choline bindingCholinesteraseHomo sapiens (human)
identical protein bindingCholinesteraseHomo sapiens (human)
amyloid-beta bindingAcetylcholinesteraseHomo sapiens (human)
acetylcholinesterase activityAcetylcholinesteraseHomo sapiens (human)
cholinesterase activityAcetylcholinesteraseHomo sapiens (human)
protein bindingAcetylcholinesteraseHomo sapiens (human)
collagen bindingAcetylcholinesteraseHomo sapiens (human)
hydrolase activityAcetylcholinesteraseHomo sapiens (human)
serine hydrolase activityAcetylcholinesteraseHomo sapiens (human)
acetylcholine bindingAcetylcholinesteraseHomo sapiens (human)
protein homodimerization activityAcetylcholinesteraseHomo sapiens (human)
laminin bindingAcetylcholinesteraseHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
double-stranded DNA bindingTAR DNA-binding protein 43Homo sapiens (human)
RNA bindingTAR DNA-binding protein 43Homo sapiens (human)
mRNA 3'-UTR bindingTAR DNA-binding protein 43Homo sapiens (human)
protein bindingTAR DNA-binding protein 43Homo sapiens (human)
lipid bindingTAR DNA-binding protein 43Homo sapiens (human)
identical protein bindingTAR DNA-binding protein 43Homo sapiens (human)
pre-mRNA intronic bindingTAR DNA-binding protein 43Homo sapiens (human)
molecular condensate scaffold activityTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (36)

Processvia Protein(s)Taxonomy
nucleoplasmNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
transcription regulator complexNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nuclear bodyNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
intermediate filament cytoskeletonNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
chromatinNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
nucleusNuclear receptor subfamily 1 group I member 2Homo sapiens (human)
basolateral plasma membraneBile salt export pumpHomo sapiens (human)
Golgi membraneBile salt export pumpHomo sapiens (human)
endosomeBile salt export pumpHomo sapiens (human)
plasma membraneBile salt export pumpHomo sapiens (human)
cell surfaceBile salt export pumpHomo sapiens (human)
apical plasma membraneBile salt export pumpHomo sapiens (human)
intercellular canaliculusBile salt export pumpHomo sapiens (human)
intracellular canaliculusBile salt export pumpHomo sapiens (human)
recycling endosomeBile salt export pumpHomo sapiens (human)
recycling endosome membraneBile salt export pumpHomo sapiens (human)
extracellular exosomeBile salt export pumpHomo sapiens (human)
membraneBile salt export pumpHomo sapiens (human)
extracellular regionCholinesteraseHomo sapiens (human)
nuclear envelope lumenCholinesteraseHomo sapiens (human)
endoplasmic reticulum lumenCholinesteraseHomo sapiens (human)
blood microparticleCholinesteraseHomo sapiens (human)
plasma membraneCholinesteraseHomo sapiens (human)
extracellular spaceCholinesteraseHomo sapiens (human)
extracellular regionAcetylcholinesteraseHomo sapiens (human)
basement membraneAcetylcholinesteraseHomo sapiens (human)
extracellular spaceAcetylcholinesteraseHomo sapiens (human)
nucleusAcetylcholinesteraseHomo sapiens (human)
Golgi apparatusAcetylcholinesteraseHomo sapiens (human)
plasma membraneAcetylcholinesteraseHomo sapiens (human)
cell surfaceAcetylcholinesteraseHomo sapiens (human)
membraneAcetylcholinesteraseHomo sapiens (human)
neuromuscular junctionAcetylcholinesteraseHomo sapiens (human)
synaptic cleftAcetylcholinesteraseHomo sapiens (human)
synapseAcetylcholinesteraseHomo sapiens (human)
perinuclear region of cytoplasmAcetylcholinesteraseHomo sapiens (human)
side of membraneAcetylcholinesteraseHomo sapiens (human)
intracellular non-membrane-bounded organelleTAR DNA-binding protein 43Homo sapiens (human)
nucleusTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
perichromatin fibrilsTAR DNA-binding protein 43Homo sapiens (human)
mitochondrionTAR DNA-binding protein 43Homo sapiens (human)
cytoplasmic stress granuleTAR DNA-binding protein 43Homo sapiens (human)
nuclear speckTAR DNA-binding protein 43Homo sapiens (human)
interchromatin granuleTAR DNA-binding protein 43Homo sapiens (human)
nucleoplasmTAR DNA-binding protein 43Homo sapiens (human)
chromatinTAR DNA-binding protein 43Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (227)

Assay IDTitleYearJournalArticle
AID286752Inhibition of carrageenan-induced Fischer 344 rat paw edema at 0.01 mmol/kg, ip2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID481540Growth inhibition of human SCC25 cells at 10 uM2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID196890Effect on in vitro myocardial electrical activity (arrhythmia score) at 5 uM2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.
AID567076Growth inhibition of human HT-29 cells at 100 uM after 24 hrs by BrdU-ELISA assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1712230Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total oxidative stress level by measuring H2O2 equivalents at 10 uM after 24 hrs (Rvb = 2.3 +/- 0.3 umol/L)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID481552Cytotoxicity against human HO8910 cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1203927Cytotoxicity against human A549 cells assessed as dose reduction index ratio treated at sequential combination at 2:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID1519402Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis
AID1712211Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as cell viability at 1 uM incubated for 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID778748Antihyperglycemic activity in rat L6 cells assessed as increase in [3H]dGlc uptake at 25 uM after 30 mins by liquid scintillation counting analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID1712224Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 10 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID481562Cytotoxicity against human PC3 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID250075Percentage increase of intracellular reactive oxygen species in neuronal cells at 0.5 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID776254Induction of HDF proliferation at 0.1 mM after 48 hrs by MTT assay relative to control2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis of lipoic acid-peptide conjugates and their effect on collagen and melanogenesis.
AID1203914Cytotoxicity against human A549 cells assessed as inhibition fraction treated at 2:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID264485Viability of rotifers against hydrogen peroxide toxicity at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID1686243Toxicity in human HepG2 cells assessed as cell viability at 1000 uM by MTT assay relative to control2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID481551Cytotoxicity against human HO8910 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID481561Cytotoxicity against human PC3 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID250065Percentage increase of intracellular reactive oxygen species in neuronal cells at 1 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID481546Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1449628Inhibition of human BSEP expressed in baculovirus transfected fall armyworm Sf21 cell membranes vesicles assessed as reduction in ATP-dependent [3H]-taurocholate transport into vesicles incubated for 5 mins by Topcount based rapid filtration method2012Drug metabolism and disposition: the biological fate of chemicals, Dec, Volume: 40, Issue:12
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
AID239871Blocking activity was assessed by antagonism of (-)-phenylephrine induced contraction of rat spleen (alpha1B adrenoceptor)2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID481545Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID481541Growth inhibition of human Detroit 562 cells at 10 uM2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID84280Neuroprotective effect was measured by its ability to protect mouse hippocampal neuronal HT-22 cell lines from oxidative stress caused by glutamate2002Bioorganic & medicinal chemistry letters, Jun-03, Volume: 12, Issue:11
Novel lipoic acid analogues that inhibit nitric oxide synthase.
AID567080Growth inhibition of human HT-29 cells at 150 uM after 48 hrs by BrdU-ELISA assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID481560Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1686234Inhibition of Electrophorus electricus AChE pre-incubated for 10 mins before addition of acetylthiocholine iodide substrate and further incubated for 15 mins by Ellman's method2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID286756Antioxidant activity assessed as DPPH reducing activity at 0.5 mM after 60 mins2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID1203902Cytotoxicity against human MRC5 cells after 48 hrs by SRB assay2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID363802Inhibition of human COX22008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
AID1519406Anti-glycation activity assessed as inhibition of AGE formation by measuring decrease in glycated BSA protein level at 100 uM incubated for 24 hrs in presence of glucose by fluorescence based assay relative to control
AID1712215Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as cell viability at 100 uM incubated for 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1519405Anti-glycation activity assessed as inhibition of AGE formation by measuring decrease in glycated BSA protein level at 1000 uM incubated for 24 hrs in presence of glucose by fluorescence based assay relative to control
AID239992Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1a expressed in CHO cells; Not tested2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID426422Antioxidant activity against hydroxyl radical assessed as inhibition of formaldehyde production at 0.1 mM after 30 mins relative to DMSO2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID778734Cytoprotective activity in rat L6 cells assessed as increase in glucose oxidase-reduced cell survival at 2 mM incubated for 30 mins prior to glucose oxidase challenge measured after 5 hrs by MTT assay in presence of 23.5 mM D-glucose2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID590976Induction of amyloid beta 40 fibril disassembly at 1:2 compound:amyloid-beta ratio2011Bioorganic & medicinal chemistry letters, Apr-15, Volume: 21, Issue:8
Proflavine derivatives as fluorescent imaging agents of amyloid deposits.
AID481556Cytotoxicity against human KB cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID264479Lipophilicity, log k'w of the compound2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID241200Inhibitory concentration against human recombinant acetylcholinesterase2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID1712222Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 0.1 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1683451Antioxidant activity in human HeLa cells assessed as decrease in nuclear ROS at 500 uM measured after 24 hrs by CellROX reagent based flow cytometry relative to control2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Novel molecular hybrids of indoline spiropyrans and α-lipoic acid as potential photopharmacological agents: Synthesis, structure, photochromic and biological properties.
AID1357859Antiproliferative activity against human HL60 cells after 72 hrs by MTT assay
AID426426Inhibition of soybean lipoxygenase assessed as conversion of sodium linoleate to 13-hydroperoxylinoleic acid at 0.1 mM2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID1203907Cytotoxicity against human T24 cells after 48 hrs by SRB assay2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID250064Percentage increase of intracellular reactive oxygen species in neuronal cells at 0 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID567082Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at G0/G1 phase at 100 uM after 24 hrs by flow cytometry (Rvb = 61.4+/-1.1%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1712232Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total oxidative stress level by measuring H2O2 equivalents at 50 uM after 24 hrs (Rvb = 2.3 +/- 0.3 umol/L)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1712216Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as LDH activity at 0.1 uM incubated for 24 hrs by LDH assay (Rvb = 0.029 +/- 0.04 mU/ml)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1357857Antiproliferative activity against human SGC7901 cells after 72 hrs by MTT assay
AID1519401Inhibition of DPP4 in human serum assessed as decrease in p-nitroaniline formation using Gly-Pro-p-nitroanilide as substrate at 100 uM preincubated for 5 mins followed by incubation with substrate for 15 mins by microplate reader analysis relative to cont
AID1712231Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total oxidative stress level by measuring H2O2 equivalents at 25 uM after 24 hrs (Rvb = 2.3 +/- 0.3 umol/L)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1712229Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total oxidative stress level by measuring H2O2 equivalents at 1 uM after 24 hrs (Rvb = 2.3 +/- 0.3 umol/L)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1712228Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total oxidative stress level by measuring H2O2 equivalents at 0.1 uM after 24 hrs (Rvb = 2.3 +/- 0.3 umol/L)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1686237Inhibition of BuChE in human erythrocyte hemo-lyzates pre-incubated for 5 mins before addition of butyrylthiocholine iodide substrate by Ellman's method2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID1712219Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as LDH activity at 25 uM incubated for 24 hrs by LDH assay (Rvb = 0.029 +/- 0.04 mU/ml)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1203938Induction of H2O2 level in human A549 cells at 1 uM after 5 mins by flow cytometry2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID239873Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat prostatic vas deferens (alpha1A adrenoceptor)2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID1686240Effective permeability at 100 uM after 3 to 6 hrs by PAMPA assay2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID668901Cytotoxicity against mouse RAW264.7 cells at 50 uM by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and effects of some novel tetrahydronaphthalene derivatives on proliferation and nitric oxide production in lipopolysaccharide activated Raw 264.7 macrophages.
AID363806Antioxidant activity assessed as hydroxyl radical scavenging activity2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
AID481558Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID481537Induction of apoptosis in human SMMC7721 cells at 5 mM after 96 hrs2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID567077Growth inhibition of human HT-29 cells at 150 uM after 24 hrs by BrdU-ELISA assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID481549Cytotoxicity against human HO8910 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1061203Cardioprotective activity in Sprague-Dawley rat model of myocardial ischemia-reperfusion injury assessed as reduction in MI/AR ratio at 1 to 10 mg/kg, iv bolus administered 15 mins prior to 30 mins LCX ligation by TTC staining-based fluorescence microscop2014Bioorganic & medicinal chemistry, Jan-01, Volume: 22, Issue:1
Lipoic acid analogs with enhanced pharmacological activity.
AID1712221Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as LDH activity at 100 uM incubated for 24 hrs by LDH assay (Rvb = 0.029 +/- 0.04 mU/ml)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1359872Inhibition of H2O2-induced ROS generation in rat PC12 cells assessed as intracellular ROS level at 50 uM preincubated for 6 hrs followed by H2O2 addition measured after 18 hrs by DCFH-DA staining based fluorimetric method relative to control2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID481553Cytotoxicity against human KB cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID197084Inhibition of in vitro peroxidation (LP) of rat Hepatic microsomal membrane lipid2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.
AID567087Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at S phase at 300 uM after 24 hrs by flow cytometry (Rvb = 21+/-0.9%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID426432Antioxidant activity assessed as reduction of DPPH activity at 0.5 mM after 20 mins2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID778729Antiapoptotic activity in rat L6 cells assessed as suppression of 23.5 mM D-glucose-induced JNK-54 phosphorylation at 2 mM after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID1712214Cytotoxicity against rat Sprague-Dawley Cerebral cortex neuron assessed as cell viability at 50 uM incubated for 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1215094Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID1215092Activation of human PXR expressed in human HepG2 (DPX-2) cells assessed as induction of CYP3A4 up to 46 uM after 24 hrs by luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID426431Antioxidant activity assessed as reduction of DPPH activity at 0.1 mM after 60 mins2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID521220Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay2007Nature chemical biology, May, Volume: 3, Issue:5
Chemical genetics reveals a complex functional ground state of neural stem cells.
AID1215091Activation of human PXR expressed in human HepG2 (DPX-2) cells up to 46 uM after 24 hrs by luciferase reporter gene based luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID1712213Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as cell viability at 25 uM incubated for 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID289322Hypochlorous acid scavenging activity assessed as inhibition of DHR oxidation2007Bioorganic & medicinal chemistry, Sep-15, Volume: 15, Issue:18
2-Styrylchromones: novel strong scavengers of reactive oxygen and nitrogen species.
AID668900Cytotoxicity against mouse RAW264.7 cells at 5 uM by MTT assay2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and effects of some novel tetrahydronaphthalene derivatives on proliferation and nitric oxide production in lipopolysaccharide activated Raw 264.7 macrophages.
AID591507Antihyperalgesic activity in rat assessed as reversal of oxaliplatin-induced mechanical hyperalgesia at 50 to 100 mg.kg, iv by paw pressure test2011Journal of medicinal chemistry, Apr-14, Volume: 54, Issue:7
Synthesis and biological evaluation of 3,7-diazabicyclo[4.3.0]nonan-8-ones as potential nootropic and analgesic drugs.
AID286757Antioxidant activity assessed as DMSO hydroxyl radical scavenging activity at 0.1 mM2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID668899Inhibition of nitrite level in LPS-induced mouse RAW264.7 cells at 50 uM by Griess assay relative to LPS treated control2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and effects of some novel tetrahydronaphthalene derivatives on proliferation and nitric oxide production in lipopolysaccharide activated Raw 264.7 macrophages.
AID250070Percentage increase of intracellular reactive oxygen species in neuronal cells at 50 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID1203930Cytotoxicity against human MRC5 cells assessed as dose reduction index ratio treated at sequential combination at 5:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID347225Antioxidant activity assessed as hydroxyl radical scavenging activity2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Diaryl-dithiolanes and -isothiazoles: COX-1/COX-2 and 5-LOX-inhibitory, *OH scavenging and anti-adhesive activities.
AID567086Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at S phase at 150 uM after 24 hrs by flow cytometry (Rvb = 21+/-0.9%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1203922Cytotoxicity against human A549 cells assessed as dose reduction index ratio treated at simultaneous combination at 0.8 fraction inhibition after 48 hrs by SRB assay in presence of alpha-lipoic acid2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID239872Blocking activity was assessed by antagonism of (-)-noradrenaline induced contraction of rat thoracic aorta (Alpha-1D adrenoceptor)2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID1357855Antiproliferative activity against human Bel7402 cells after 72 hrs by MTT assay
AID1712218Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as LDH activity at 10 uM incubated for 24 hrs by LDH assay2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID286753Antioxidant activity assessed as DPPH reducing activity at 0.1 mM after 20 mins2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID567090Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at G2/M phase at 300 uM after 24 hrs by flow cytometry (Rvb = 17.6+/-1%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1519408Metal chelating activity assessed as inhibition of Cu2+ ion-induced oxidation of ascorbic acid compound treated with CuSO4.5H2O for 5 mins followed by ascorbate addition and measured immediately by spectrophotometric analysis
AID1203929Cytotoxicity against human MRC5 cells assessed as dose reduction index ratio treated at sequential combination at 2:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID286755Antioxidant activity assessed as DPPH reducing activity at 0.5 mM after 20 mins2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID778736Effect on total GLUT4 level in rat L6 cells at 2 mM after 30 mins by Western blotting analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID239827Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1d expressed in CHO cells; Not tested2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID197086Evaluated for the interaction with 0.2 mM of the stable free radical DPPH.2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.
AID481557Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 100 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID241230Inhibitory concentration against human recombinant butyrylcholinesterase2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID363800Inhibition of bovine COX12008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
AID264480Hydroxyl radical scavenging activity by ABTS competition assay per 30 mins at 1 umol/mL2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID625546Inhibition of human serum recombinant AChE after 20 mins using acetylthiocholine iodide as a substrate by Ellman's assay2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
AID1666489Inhibition of TDP-43 (unknown origin) binding to RNA2020Bioorganic & medicinal chemistry letters, 02-15, Volume: 30, Issue:4
Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia.
AID1712233Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total oxidative stress level by measuring H2O2 equivalents at 100 uM after 24 hrs (Rvb = 2.3 +/- 0.3 umol/L)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID481555Cytotoxicity against human KB cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1203928Cytotoxicity against human A549 cells assessed as dose reduction index ratio treated at sequential combination at 5:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID668898Inhibition of nitrite level in LPS-induced mouse RAW264.7 cells at 5 uM by Griess assay relative to LPS treated control2011European journal of medicinal chemistry, Feb, Volume: 46, Issue:2
Synthesis and effects of some novel tetrahydronaphthalene derivatives on proliferation and nitric oxide production in lipopolysaccharide activated Raw 264.7 macrophages.
AID248936Antiproliferative activity was determined by colorimetric MTS assay in LNCaP cells after 72 hr of incubation with compounds (1-100 uM); Not active at 100 uM2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID567081Growth inhibition of human HT-29 cells at 300 uM after 48 hrs by BrdU-ELISA assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1203917Cytotoxicity against human A549 cells assessed as inhibition fraction treated at 5:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID363804Inhibition of bovine 5LOX2008European journal of medicinal chemistry, Jun, Volume: 43, Issue:6
Investigations concerning the COX/5-LOX inhibiting and hydroxyl radical scavenging potencies of novel 4,5-diaryl isoselenazoles.
AID426433Antioxidant activity assessed as reduction of DPPH activity at 0.5 mM after 60 mins2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID778750Antihyperglycemic activity in rat L6 cells assessed as increase in [3H]dGlc uptake at 2 mM after 30 mins by liquid scintillation counting analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID776255Cytotoxicity against HDF at 0.5 to 5 mM after 48 hrs by MTT assay2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis of lipoic acid-peptide conjugates and their effect on collagen and melanogenesis.
AID264484Inhibition of doxorubicin-induced death of mixed cortical cells of E15 Sprague-Dawley rat embryo at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID481543Toxicity in rat2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1215093Activation of rat PXR expressed in human HepG2 cells up to 46 uM after 24 hrs by luciferase reporter gene based luminescent analysis2011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID481548Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID264483Inhibition of peroxynitrite-induced death of mixed cortical cells of E15 Sprague-Dawley rat embryo at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID196903Effect on in vitro accumulation of MDA content in heart, at conc of 5 uM2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.
AID1359874Inhibition of H2O2-induced ROS generation in rat PC12 cells assessed as intracellular ROS level at 5 uM preincubated for 6 hrs followed by H2O2 addition measured after 18 hrs by DCFH-DA staining based fluorimetric method relative to control2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1712212Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as cell viability at 10 uM incubated for 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID778746Induction of human myc epitope-tagged GLUT1 translocation to plasma membrane overexpressed in rat L6 cells at 2 mM after 30 mins by immunocolorimetric analysis in presence of 23.5 mM D-glucose2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID250074Percentage increase of intracellular reactive oxygen species in neuronal cells at 0.1 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID481564Cytotoxicity against human PC3 cells assessed as growth inhibition at 0.1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID481538Growth inhibition of human FADU cells at 10 uM2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1683452Antioxidant activity in human HeLa cells assessed as decrease in mitochondrial ROS at 500 uM measured after 24 hrs by CellROX reagent based flow cytometry relative to control2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Novel molecular hybrids of indoline spiropyrans and α-lipoic acid as potential photopharmacological agents: Synthesis, structure, photochromic and biological properties.
AID567078Growth inhibition of human HT-29 cells at 300 uM after 24 hrs by BrdU-ELISA assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID147106In vitro inhibition concentration was evaluated on the effect of conversion by Nitric Oxide synthase of [3H]L-arginine into [3H]L-citrulline; Not active up to 100 uM2002Bioorganic & medicinal chemistry letters, Jun-03, Volume: 12, Issue:11
Novel lipoic acid analogues that inhibit nitric oxide synthase.
AID1203924Cytotoxicity against human A549 cells assessed as dose reduction index ratio treated at simultaneous combination at 5:1 compound to GEM ratio after 48 hrs by SRB assay in presence of GEM2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID567089Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at G2/M phase at 150 uM after 24 hrs by flow cytometry (Rvb = 17.6+/-1%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID264482Inhibition of hydrogen peroxide-induced death of mixed cortical cells of E15 Sprague-Dawley rat embryo at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID1359873Inhibition of H2O2-induced ROS generation in rat PC12 cells assessed as intracellular ROS level at 10 uM preincubated for 6 hrs followed by H2O2 addition measured after 18 hrs by DCFH-DA staining based fluorimetric method relative to control2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1686242Toxicity in human HepG2 cells assessed as cell viability at 300 uM by MTT assay relative to control2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID264486Viability of rotifers against doxorubicin toxicity at 10 uM2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID286751Inhibition of soybean lipoxygenase at 0.1 mM2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID314093Inhibition of human AchE-induced amyloid beta aggregation at 100 uM2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Multi-target-directed ligands to combat neurodegenerative diseases.
AID1203897Cytotoxicity against human A549 cells after 48 hrs by SRB assay2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID481542Induction of apoptosis in human HT-29 cells2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID567088Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at G2/M phase at 100 uM after 24 hrs by flow cytometry (Rvb = 17.6+/-1%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1053269Inhibition of COX-1 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products at 500 uM preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method relative to control2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
AID383202Antioxidant scavenging activity against AAPH-induced peroxyl radical assessed as trolox equivalent per uM of compound by ORAC-fluorescein assay2008Bioorganic & medicinal chemistry, Apr-15, Volume: 16, Issue:8
Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.
AID778732Antioxidant activity in rat L6 cells assessed as trolox equivalents of ABTS free radical scavenging activity at 2 mM after 2 hrs by ELISA reader analysis in presence of 23.5 mM D-glucose2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID625547Inhibition of human serum recombinant BChE after 20 mins using butyrylthiocholine iodide as a substrate by Ellman's assay2011European journal of medicinal chemistry, Nov, Volume: 46, Issue:11
Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer's disease.
AID481539Growth inhibition of human SCC9 cells at 10 uM2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID336478Inhibition of COX2 at 100 uM by scintillation proximity assay2002Journal of natural products, Nov, Volume: 65, Issue:11
Screening of ubiquitous plant constituents for COX-2 inhibition with a scintillation proximity based assay.
AID250069Percentage increase of intracellular reactive oxygen species in neuronal cells at 10 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID1683456Cytotoxicity against human HeLa cells assessed as effect on cell viability at 500 uM measured after 24 hrs (Rvb (2% DMSO) = 93.5 +/- 3.19 %)2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Novel molecular hybrids of indoline spiropyrans and α-lipoic acid as potential photopharmacological agents: Synthesis, structure, photochromic and biological properties.
AID778741Effect on human myc epitope-tagged total GLUT1 level overexpressed in rat L6 cells at 2 mM after 30 mins by Western blotting analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID1359877Antioxidant activity assessed as ferric ion reducing activity by measuring Fe2+ levels at 10 uM using Fe2+-TPTZ after 15 mins by FRAP assay2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID1712227Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 100 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID426427In vivo antiinflammatory activity in Fisher 344 rat assessed as inhibition of carrageenan-induced paw edema at 0.01 mmol/kg, ip administered simultaneously with carrageenan measured after 3.5 hrs2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID567083Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at G0/G1 phase at 150 uM after 24 hrs by flow cytometry (Rvb = 61.4+/-1.1%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1683450Antioxidant activity in human HeLa cells assessed as increase in cellular thiol level at 2 mM measured after 24 hrs by Thiol-tracker violet molecular probe based assay relative to control2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Novel molecular hybrids of indoline spiropyrans and α-lipoic acid as potential photopharmacological agents: Synthesis, structure, photochromic and biological properties.
AID286754Antioxidant activity assessed as DPPH reducing activity at 0.1 mM after 60 mins2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
Design and synthesis of novel quinolinone-3-aminoamides and their alpha-lipoic acid adducts as antioxidant and anti-inflammatory agents.
AID567079Growth inhibition of human HT-29 cells at 100 uM after 48 hrs by BrdU-ELISA assay2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1357858Antiproliferative activity against human Caco2 cells after 72 hrs by MTT assay
AID778728Antiapoptotic activity in rat L6 cells assessed as suppression of 23.5 mM D-glucose-induced JNK-46 phosphorylation at 2 mM after 30 mins by Western blot analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID1359875Inhibition of H2O2-induced ROS generation in rat PC12 cells assessed as intracellular ROS level at 1 uM preincubated for 6 hrs followed by H2O2 addition measured after 18 hrs by DCFH-DA staining based fluorimetric method relative to control2018European journal of medicinal chemistry, May-25, Volume: 152Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer's disease based on coumarin and lipoic acid scaffolds.
AID426430Antioxidant activity assessed as reduction of DPPH activity at 0.1 mM after 20 mins2009European journal of medicinal chemistry, Jul, Volume: 44, Issue:7
Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts.
AID778740Effect on human myc epitope-tagged total GLUT4 level overexpressed in rat L6 cells at 2 mM after 30 mins by Western blotting analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID1686239Antioxidant activity assessed as AAPH radical scavenging activity incubated for 15 mins by ORAC-FL method relative to Trolox2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID1203920Cytotoxicity against human A549 cells assessed as inhibition fraction treated at sequential combination LA + compound sequent. compound for 24 hrs, LA + compound for 24 hrs additional, total 48 hrs 2:1 and 5:1 compound to GEM ratio after 48 hrs by SRB ass2015European journal of medicinal chemistry, , Volume: 96Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
AID1712217Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as LDH activity at 1 uM incubated for 24 hrs by LDH assay (Rvb = 0.029 +/- 0.04 mU/ml)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID314091Inhibition of human AchE2008Journal of medicinal chemistry, Feb-14, Volume: 51, Issue:3
Multi-target-directed ligands to combat neurodegenerative diseases.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID776261Inhibition of mushroom tyrosinase using L-DOPA as substrate at 2.5 mM preincubated for 10 to 15 mins prior to substrate addition by spectrophotometry2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis of lipoic acid-peptide conjugates and their effect on collagen and melanogenesis.
AID1357856Antiproliferative activity against human MCF7 cells after 72 hrs by MTT assay
AID481554Cytotoxicity against human KB cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID481550Cytotoxicity against human HO8910 cells assessed as growth inhibition at 10 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1683454Cytotoxicity against human HeLa cells assessed as decrease in cell viability at 2 mM measured after 24 hrs relative to 8% DMSO control2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Novel molecular hybrids of indoline spiropyrans and α-lipoic acid as potential photopharmacological agents: Synthesis, structure, photochromic and biological properties.
AID481563Cytotoxicity against human PC3 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID776264Cytotoxicity against mouse B16F10 cells assessed as cell viability after 48 hrs by MTT assay2013European journal of medicinal chemistry, Nov, Volume: 69Synthesis of lipoic acid-peptide conjugates and their effect on collagen and melanogenesis.
AID1683455Cytotoxicity against human HeLa cells assessed as effect on cell viability at 2 mM measured after 24 hrs (Rvb (8% DMSO) = 79.08 +/- 10.78 %)2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Novel molecular hybrids of indoline spiropyrans and α-lipoic acid as potential photopharmacological agents: Synthesis, structure, photochromic and biological properties.
AID1357860Antiproliferative activity against human PBMC cells after 72 hrs by MTT assay
AID481547Cytotoxicity against human NCI-H460 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID1686235Inhibition of horse serum BuChE pre-incubated for 10 mins before addition of butyrylthiocholine iodide substrate and further incubated for 15 mins by Ellman's method2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID1215095Competitive binding affinity to human PXR LBD (111 to 434) by TR-FRET assay relative to SR128132011Drug metabolism and disposition: the biological fate of chemicals, Jan, Volume: 39, Issue:1
Identification of clinically used drugs that activate pregnane X receptors.
AID239826Equilibrium dissociation constant was evaluated by radio-receptor binding assays using [3H]prazosin to label cloned human alpha 1b expressed in CHO cells; Not tested2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID1712226Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 50 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1686241Toxicity in human HepG2 cells assessed as cell viability at 100 uM by MTT assay relative to control2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID1053268Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate assessed as formation of prostanoid products at 500 uM preincubated for 10 mins prior to substrate addition measured after 2 mins by Ellman's method relative to control2013Journal of medicinal chemistry, Nov-14, Volume: 56, Issue:21
Experimental confirmation of new drug-target interactions predicted by Drug Profile Matching.
AID567085Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at S phase at 100 uM after 24 hrs by flow cytometry (Rvb = 21+/-0.9%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID1712223Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 1 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1712210Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as cell viability at 0.1 uM incubated for 24 hrs by MTT assay relative to control2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID772966Neuroprotective activity in 3 days postfertilized zebrafish larvae assessed as reduction of all-trans retinoic acid-induced apoptosis at 1 uM after 24 hrs by fluorescence microscopy2013Bioorganic & medicinal chemistry letters, Oct-15, Volume: 23, Issue:20
Generation by mutasynthesis of potential neuroprotectant derivatives of the bipyridyl collismycin A.
AID248861Antioxidant activity against formation of ROS was determined in t-BuOOH treated LNCaP cells after 24 hr of incubation with compounds (1-100 uM)2005Journal of medicinal chemistry, Jan-13, Volume: 48, Issue:1
Design, synthesis, and biological evaluation of prazosin-related derivatives as multipotent compounds.
AID127631Ability for prevention of GSH depletion was measured in mouse2002Bioorganic & medicinal chemistry letters, Jun-03, Volume: 12, Issue:11
Novel lipoic acid analogues that inhibit nitric oxide synthase.
AID481559Cytotoxicity against human Bel7402 cells assessed as growth inhibition at 1 ug/ml after 24 hrs by MTT assay2010Bioorganic & medicinal chemistry letters, May-15, Volume: 20, Issue:10
Synthesis and anticancer evaluation of alpha-lipoic acid derivatives.
AID264481Radical reducing potency by ABTS cation radical reduction assay per 30 mins at 1 umol/mL2006Journal of medicinal chemistry, May-04, Volume: 49, Issue:9
Fluorinated amphiphilic amino acid derivatives as antioxidant carriers: a new class of protective agents.
AID1712220Cytotoxicity against Sprague-Dawley rat Cerebral cortex neuron assessed as LDH activity at 50 uM incubated for 24 hrs by LDH assay (Rvb = 0.029 +/- 0.04 mU/ml)2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID1519407Anti-glycation activity assessed as inhibition of AGE formation by measuring decrease in glycated BSA protein level incubated for 24 hrs in presence of glucose by fluorescence based assay
AID453279Antioxidant activity assessed as hypochlorous acid scavenging activity by fluorescent rhodamine formation assay2009Bioorganic & medicinal chemistry, Oct-15, Volume: 17, Issue:20
Synthesis and antioxidant properties of new chromone derivatives.
AID1712225Antioxidant activity in Sprague-Dawley rat Cerebral cortex neuron assessed as total antioxidant capacity by measuring trolox equivalents at 25 uM after 24 hrs2016Bioorganic & medicinal chemistry, 07-15, Volume: 24, Issue:14
New bifunctional antioxidant/σ1 agonist ligands: Preliminary chemico-physical and biological evaluation.
AID27921The compound was evaluated for lipophilicity.2001Journal of medicinal chemistry, Nov-22, Volume: 44, Issue:24
Novel potent inhibitors of lipid peroxidation with protective effects against reperfusion arrhythmias.
AID1686236Inhibition of AChE in human erythrocyte hemo-lyzates pre-incubated for 5 mins before addition of acetylthiocholine iodide substrate by Ellman's method2016Journal of medicinal chemistry, 11-10, Volume: 59, Issue:21
The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
AID778737Effect on total GLUT1 level in rat L6 cells at 2 mM after 30 mins by Western blotting analysis2013Journal of medicinal chemistry, Sep-12, Volume: 56, Issue:17
Multifunctional cyclic D,L-α-peptide architectures stimulate non-insulin dependent glucose uptake in skeletal muscle cells and protect them against oxidative stress.
AID567084Induction of cell cycle arrest in human HT-29 cells assessed as accumulation at G0/G1 phase at 300 uM after 24 hrs by flow cytometry (Rvb = 61.4+/-1.1%)2011European journal of medicinal chemistry, Jan, Volume: 46, Issue:1
Synthesis of a novel ester of hydroxytyrosol and α-lipoic acid exhibiting an antiproliferative effect on human colon cancer HT-29 cells.
AID250066Percentage increase of intracellular reactive oxygen species in neuronal cells at 5 uM2005Journal of medicinal chemistry, Jan-27, Volume: 48, Issue:2
Rational approach to discover multipotent anti-Alzheimer drugs.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347410qHTS for inhibitors of adenylyl cyclases using a fission yeast platform: a pilot screen against the NCATS LOPAC library2019Cellular signalling, 08, Volume: 60A fission yeast platform for heterologous expression of mammalian adenylyl cyclases and high throughput screening.
AID1347151Optimization of GU AMC qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347058CD47-SIRPalpha protein protein interaction - HTRF assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347057CD47-SIRPalpha protein protein interaction - LANCE assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347059CD47-SIRPalpha protein protein interaction - Alpha assay qHTS validation2019PloS one, , Volume: 14, Issue:7
Quantitative high-throughput screening assays for the discovery and development of SIRPα-CD47 interaction inhibitors.
AID1347405qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS LOPAC collection2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (55)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's20 (36.36)29.6817
2010's26 (47.27)24.3611
2020's9 (16.36)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 43.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index43.65 (24.57)
Research Supply Index4.06 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index65.23 (26.88)
Search Engine Supply Index2.05 (0.95)

This Compound (43.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (3.64%)5.53%
Reviews3 (5.45%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other50 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]